VL-PX10/VL-P22 / Vitti Labs, Trinitas Regional Medical Center - LARVOL DELTA

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19) (clinicaltrials.gov) - P1 | N=20 | Suspended | Sponsor: Vitti Labs, LLC | Trial completion date: Dec 2023 ➔ Dec 2025 | Recruiting ➔ Suspended | Trial primary completion date: Oct 2023 ➔ Oct 2025

Trial completion date • Trial primary completion date • Trial suspension • Acute Respiratory Distress Syndrome • Infectious Disease • Novel Coronavirus Disease • Pulmonary Disease • Respiratory Diseases

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19) (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Vitti Labs, LLC | Trial completion date: Dec 2022 ➔ Dec 2023 | Initiation date: Jun 2022 ➔ Mar 2023 | Trial primary completion date: Oct 2022 ➔ Oct 2023

Trial completion date • Trial initiation date • Trial primary completion date • Acute Respiratory Distress Syndrome • Infectious Disease • Novel Coronavirus Disease • Pulmonary Disease • Respiratory Diseases

Safety and Effectiveness of EV-Pure + WJ-Pure Treatment on Pulmonary Fibrosis Secondary to Covid-19 (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Vitti Labs, LLC | Trial completion date: Dec 2022 ➔ Dec 2023 | Initiation date: Jun 2022 ➔ Nov 2022 | Trial primary completion date: Oct 2022 ➔ Nov 2023

Trial completion date • Trial initiation date • Trial primary completion date • Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Infectious Disease • Novel Coronavirus Disease • Pulmonary Disease • Respiratory Diseases

Safety and Effectiveness of EV-Pure + WJ-Pure Treatment on Pulmonary Fibrosis Secondary to Covid-19 (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Vitti Labs, LLC

New P1 trial • Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Infectious Disease • Novel Coronavirus Disease • Pulmonary Disease • Respiratory Diseases

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19) (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Vitti Labs, LLC

New P1 trial • Acute Respiratory Distress Syndrome • Infectious Disease • Novel Coronavirus Disease • Pulmonary Disease • Respiratory Diseases